Endostar First-line Treatment of Advanced Non-small Cell Lung Squamous Carcinoma

NCT02513342 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

400

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Lung Squamous Carcinoma

Interventions

BIOLOGICAL: Endostar
DRUG: Docetaxel
DRUG: Cisplatin

Sponsor

Nanjing NingQi Medicine Science and Technology Co., Ltd.